Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Enagas (ENAG.MC)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (€)	Price Target (€)	Rating
2022-03-30	19.94	18.90	Neutral
2022-04-27	20.75	19.60	Neutral
2022-10-24	15.19	14.60	Neutral
2023-01-19	16.67	15.30	Neutral
2023-04-26	17.66	16.85	Neutral
2023-10-20	15.78	15.85	Neutral
2024-02-16	14.48	14.50	Neutral
2024-04-26	13.78	14.35	Neutral
2024-07-15	13.38	14.30	Neutral
2025-01-08	11.99	12.45	Neutral
2025-03-03	12.35	12.85	Neutral
2025-04-29	13.54	13.25	Neutral
2025-06-16	14.20	13.55	Neutral

Disclosures

UBS holds a long or short position of 0.5% or more of the listed shares of this company.

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.